GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Other Current Payables

Incanthera (AQSE:INC) Other Current Payables : £0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Other Current Payables?

Incanthera's Other Current Payables for the quarter that ended in Sep. 2023 was £0.00 Mil.

Incanthera's quarterly Other Current Payables increased from Sep. 2022 (£0.00 Mil) to Mar. 2023 (£0.06 Mil) but then declined from Mar. 2023 (£0.06 Mil) to Sep. 2023 (£0.00 Mil).

Incanthera's annual Other Current Payables increased from Mar. 2021 (£-0.01 Mil) to Mar. 2022 (£-0.01 Mil) and increased from Mar. 2022 (£-0.01 Mil) to Mar. 2023 (£0.06 Mil).


Incanthera Other Current Payables Historical Data

The historical data trend for Incanthera's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Other Current Payables Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Other Current Payables
- -0.01 -0.01 0.06

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Current Payables Get a 7-Day Free Trial - -0.01 - 0.06 -

Incanthera Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Incanthera Other Current Payables Related Terms

Thank you for viewing the detailed overview of Incanthera's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines